Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Since february 16 2007 medtronic has received 29 reports of occurrence of lead damage when using the lead cap. depending on the extent of lead damage and the need to use the affected contact(s) and conductor(s) lead replacement may be required exposing the patient to the risks of a second lead implant procedure.
Model Catalog: 3387-40 (Lot serial: ALL LOTS); Model Catalog: 3387-28 (Lot serial: ALL LOTS); Model Catalog: 3389-28 (Lot serial: ALL LOTS); Model Catalog: 3389-40 (Lot serial: ALL LOTS)
“If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.